AQST - Aquestive Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

253.4M

Cash

95.2M

Avg Qtr Burn

-6.395M

Short % of Float

12.97%

Insider Ownership

5.03%

Institutional Own.

46.59%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
LIBERVANT™ (Diazepam) Buccal Film Details Seizures	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ZUPLENZ (ondansetron) Details Nausea and vomiting	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KYNMOBI™ (apomorphine HCI) sublingual film (APL-130277) Details Parkinson’s disease (OFF Episodes / motor fluctuations)	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Exservan™ (riluzole) Oral Film Details Amyotrophic Lateral Sclerosis (ALS)	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SUBOXONE (buprenorphine/naloxone) Details Opioid addiction	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Anaphylm (Epinephrine) Sublingual Film (AQST-109) Details Anaphylaxis	NDA FDA meeting	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AQST-108 (epinephrine) Topical Gel Details Skin disease/disorder	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AQST-119 Details Erectile dysfunction	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.